Our Chemistry

Over the past 25 years the Bradley group has employed peptide chemistry at the interface of medicine and chemistry from arrays to bacterial probes.

Over the past 10 years the Bradley group has had a very close relationship with the groups of Professor Chris Haslett and Dr Kev Dhaliwal (both in the Medical School) in the area of Optical Molecular Imaging.

The Bradley group has developed a number of chemistry-based approaches in which molecules can be activated (switched-on) or synthesised (generated) within biological systems by the aid of chemical catalysts.

Polymeric biomaterials have become an integral part of the biomedical arena, with applications ranging from the basic (blood bags and catheters) to the complex (tissue engineering scaffolds and drug delivery devices).

The Bradley group is currently involved in a multidisciplinary project called IMPACT (Implantable Microsystems for Personalised Anti-Cancer Therapy) led by Professor Alan Murray (University’s School of Engineering). The whole team consists of engineers, chemists, veterinary scientists, social scientists and human cancer specialists working together.

The need for smartness